{"id":"https://genegraph.clinicalgenome.org/r/26526dcb-c229-4a3d-88ed-af150d0c6a1av1.0","type":"EvidenceStrengthAssertion","dc:description":"Juvenile polyposis syndrome (JPS) is characterized by predisposition to hamartomatous polyps in the gastrointestinal (GI) tract, specifically in the stomach, small intestine, colon, and rectum. The term \"juvenile\" refers to the type of polyp rather than to the age of onset of polyps.ENG was first reported in relation to autosomal dominant JPS in 2005 (Sweet et al., PMID: 16287957).  ENG (Endoglin) is a component of the transforming growth factor beta (TGFB) receptor complex and binds TGFB1 with a crucial role in vascular development and angiogenesis. Haploinsufficient variants account for over 85% of patients with a clinical diagnosis of hereditary hemorrhagic telangiectasia (HHT) and have been found to have a Definitive relationship with HHT (see separate curation).  Variants in ENG genes were subsequently reported in patients with JPS without overlapped HHT phenotype. Therefore, per the ClinGen Lumping and Splitting Working Group this curation solely focuses on JPS phenotype with regard to curating the limited information available for this split curation. Seven missense variants that have been reported in eight probands in three publications (PMIDs: 16287957, 17204053, 23399955) are included in this curation. All of these JPS associated ENG variants are variants of uncertain pathogenicity (0.3 point). There were two research articles showing endoglin expression was increased in various cancer tissues including colon (1 point). Combination of genetic and experimental evidence has not demonstrated convincing definitive validity of ENG gene in inherited JPS. In summary, there is limited evidence to support this gene-disease relationship.","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/26526dcb-c229-4a3d-88ed-af150d0c6a1a","GCISnapshot":"https://genegraph.clinicalgenome.org/r/08c5b377-a2a1-44ac-9b7e-dc2141ee7a04","calculatedEvidenceStrength":"Limited","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/08c5b377-a2a1-44ac-9b7e-dc2141ee7a04_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10023","date":"2022-12-30T18:00:00.000Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/08c5b377-a2a1-44ac-9b7e-dc2141ee7a04_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10023","date":"2022-12-30T21:58:19.808Z","role":"Publisher"}],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/08c5b377-a2a1-44ac-9b7e-dc2141ee7a04_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e6232488-83d3-4140-a10c-c3d04f980099","type":"EvidenceLine","dc:description":"This case is from a prospectively referred cohort of 603 patients with Juvenile polyposis syndrome (JPS). In total, 11 patients carry ENG gene variants. All missense variants. This one is classified contradictorily in ClinVar. This variant occur in 9 patients with hyperplastic/serrated polyps. \n","calculatedScore":0.1,"direction":"Contradicts","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e6232488-83d3-4140-a10c-c3d04f980099_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23399955","allele":{"id":"https://genegraph.clinicalgenome.org/r/e93430e7-193b-4c23-a0cc-b5139b57fec6","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001114753.3(ENG):c.572G>A (p.Gly191Asp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA325327"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/4591a3af-2ffd-4dc0-ae74-0ffc087360be","type":"EvidenceLine","dc:description":"This case is from a prospectively referred cohort of 603 patients with Juvenile polyposis syndrome (JPS). In total, 11 patients carry ENG gene variants. All are missense variants. ","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4591a3af-2ffd-4dc0-ae74-0ffc087360be_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23399955","allele":{"id":"https://genegraph.clinicalgenome.org/r/fa661c02-73bf-4bd7-a8ee-1654dbb15edc","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001114753.3(ENG):c.154G>A (p.Gly52Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA374989036"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/94a01bc8-9913-4e48-b4a6-0b8baf5cec6d","type":"EvidenceLine","dc:description":"This case is from a prospectively referred cohort of 603 patients with Juvenile polyposis syndrome (JPS). In total, 11 patients carry ENG gene variants. All missense variants. This one is classified contradictorily in ClinVar. \n","calculatedScore":0.1,"direction":"Contradicts","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/94a01bc8-9913-4e48-b4a6-0b8baf5cec6d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23399955","allele":{"id":"https://genegraph.clinicalgenome.org/r/214fb284-ab27-4ee6-af72-5a707f406287","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001114753.3(ENG):c.392C>T (p.Pro131Leu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA202695"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/524c38e5-d015-4de0-ad34-d84bda4d79b7","type":"EvidenceLine","dc:description":"ClinVar classfies this variant as B/LB. ","calculatedScore":0.1,"direction":"Contradicts","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/524c38e5-d015-4de0-ad34-d84bda4d79b7_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17204053","allele":{"id":"https://genegraph.clinicalgenome.org/r/d3ea7ed8-83e6-4bc1-9638-0dce25c2b172","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001114753.3(ENG):c.1096G>C (p.Asp366His)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA295468"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/ac09abb4-b90d-43ed-9d59-8a4c8577b298","type":"EvidenceLine","dc:description":"ClinVar has contradictory clasiffication. LB/B","calculatedScore":0.1,"direction":"Contradicts","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ac09abb4-b90d-43ed-9d59-8a4c8577b298_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17204053","allele":{"id":"https://genegraph.clinicalgenome.org/r/3c582eef-1f45-453b-8996-b5f6bb6cf083","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001114753.3(ENG):c.14C>T (p.Thr5Met)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA295808"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/a1c68af2-eb9b-44c0-9379-c9feb90f78d7","type":"EvidenceLine","dc:description":"This case is from a prospectively referred cohort of 603 patients with Juvenile polyposis syndrome (JPS). In total, 11 patients carry ENG gene variants. All missense variants. This one is classified contradictorily in ClinVar. ","calculatedScore":0.1,"direction":"Contradicts","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a1c68af2-eb9b-44c0-9379-c9feb90f78d7_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23399955","allele":{"id":"https://genegraph.clinicalgenome.org/r/214fb284-ab27-4ee6-af72-5a707f406287"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/dd2062b8-30c2-4aa8-8574-45dec3734717","type":"EvidenceLine","dc:description":"This case is from a prospectively referred cohort of 603 patients with Juvenile polyposis syndrome (JPS). In total, 11 patients carry ENG gene variants. All missense variants. ","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/dd2062b8-30c2-4aa8-8574-45dec3734717_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23399955","allele":{"id":"https://genegraph.clinicalgenome.org/r/36898b23-9208-4d17-ac7a-c8250d05df26","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001114753.3(ENG):c.1274C>T (p.Ala425Val)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA211417"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/fde2e8b7-ddc5-45bc-b511-4d4f8b3b2994","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fde2e8b7-ddc5-45bc-b511-4d4f8b3b2994_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16287957","allele":{"id":"https://genegraph.clinicalgenome.org/r/50c2b9f3-84d6-4d9f-ba28-09ab06a3bd21","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001114753.3(ENG):c.1711C>T (p.Arg571Cys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA5252673"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":0.3},{"id":"https://genegraph.clinicalgenome.org/r/08c5b377-a2a1-44ac-9b7e-dc2141ee7a04_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/08c5b377-a2a1-44ac-9b7e-dc2141ee7a04_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ec17296e-de0c-4b9b-b412-8c3afb623d33","type":"EvidenceLine","dc:description":"Endoglin expression was intense and restricted to capillary endothelial cells in cancer lesions (>73%) by IHC on resected cancer tissues from 188 patients of various cancers including colon.  Positive expression of CD105 was seen in <20% of non-cancerous areas in the same organs. ","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d5bffb77-838a-4268-8a5b-c3a916c2ade8","type":"Finding","dc:description":"Endoglin (CD105) is a cell membrane glycoprotein and a specific marker of newly formed blood vessels.  Positive expression of CD105 was seen in <20% of non-cancerous areas in the same organs. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17096728","rdfs:label":"Histological assessment-IHC","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/cb2e6dfd-6e55-457a-99a0-d170aa1185e5","type":"EvidenceLine","dc:description":"Endoglin (CD105), a co-receptor involved in TGFÎ² signaling, is a proliferation-associated antigen of endothelial cells and essential for tumor angiogenesis. Endoglin expression showed higher expression in DMH induced colon cancer (adenocarcinoma, dysplasia and inflammation) tissue in rat.  A decrease was detected in the celecoxib-treated groups, suggesting that endoglin may be essential for tumor angiogenesis.  ","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/507f72a2-6dd9-42bb-aa89-a669844a3391","type":"Finding","dc:description":"Endoglin (ENG/CD105) expression was observed to be higher in the DMH-treated group compared to the control group (p<0.001). Western blot analysis of endoglin also showed that NSAIDs co-administration reduced the expression of endoglin with respect to the group treated with DMH alone, which suggests that endoglin may be essential for tumor angiogenesis.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27466499","rdfs:label":"Western blot analysis ","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":1}],"evidenceStrength":"Limited","sequence":5607,"specifiedBy":"GeneValidityCriteria9","strengthScore":1.3,"subject":{"id":"https://genegraph.clinicalgenome.org/r/5bg_X6cdcXs","type":"GeneValidityProposition","disease":"obo:MONDO_0017380","gene":"hgnc:3349","modeOfInheritance":"obo:HP_0000006"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_08c5b377-a2a1-44ac-9b7e-dc2141ee7a04-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}